Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Plos One
|
July 7, 2015
Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
Euphemia Y Leung, Marjan Askarian-Amiri, Graeme J Finlay, et al.
Cancer Genetics
|
October 25, 2011
Centrosomal dysregulation in human metastatic melanoma cell lines
Geoffrey A Charters, Clare J Stones, Andrew N Shelling, et al.
Investigational New Drugs
|
June 23, 2010
Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide
Catherine J Drummond, Graeme J Finlay, Laura Broome, et al.
Investigational New Drugs
|
August 11, 2010
In vivo and in vitro assessment of the action of SN 28049, a benzonaphthyridine derivative targeting topoisomerase II, on the murine Colon 38 carcinoma
Ying Yi Chen, Graeme J Finlay, James A Kirker, et al.
Bioorganic & Medicinal Chemistry
|
May 2, 2002
Synthesis and cytotoxic activity of N-(2-diethylamino)ethylcarboxamide and other derivatives of 10H-quindoline
Junjie Chen, Leslie W Deady, Anthony J Kaye, et al.
Plos One
|
August 30, 2014
Relationships between signaling pathway usage and sensitivity to a pathway inhibitor: examination of trametinib responses in cultured breast cancer lines
Euphemia Y Leung, Ji Eun Kim, Marjan Askarian-Amiri, et al.
Cancer Chemotherapy and Pharmacology
|
September 17, 2013
Tumour tissue selectivity in the uptake and retention of SN 28049, a new topoisomerase II-directed anticancer agent
Pradeep B Lukka, Ying Yi Chen, Graeme J Finlay, et al.
Frontiers in Oncology
|
September 21, 2017
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
Euphemia Y Leung, Marjan E Askarian-Amiri, Debina Sarkar, et al.
Biology Direct
|
November 23, 2016
ZFAS1: a long noncoding RNA associated with ribosomes in breast cancer cells
Herah Hansji, Euphemia Y Leung, Bruce C Baguley, et al.
Cancer Chemotherapy and Pharmacology
|
May 8, 2014
Selective cellular uptake and retention of SN 28049, a new DNA-binding topoisomerase II-directed antitumor agent
Ying Yi Chen, Pradeep B Lukka, Wayne R Joseph, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Plos One
|
July 7, 2015
Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
Euphemia Y Leung, Marjan Askarian-Amiri, Graeme J Finlay, et al.
Cancer Genetics
|
October 25, 2011
Centrosomal dysregulation in human metastatic melanoma cell lines
Geoffrey A Charters, Clare J Stones, Andrew N Shelling, et al.
Investigational New Drugs
|
June 23, 2010
Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide
Catherine J Drummond, Graeme J Finlay, Laura Broome, et al.
Investigational New Drugs
|
August 11, 2010
In vivo and in vitro assessment of the action of SN 28049, a benzonaphthyridine derivative targeting topoisomerase II, on the murine Colon 38 carcinoma
Ying Yi Chen, Graeme J Finlay, James A Kirker, et al.
Bioorganic & Medicinal Chemistry
|
May 2, 2002
Synthesis and cytotoxic activity of N-(2-diethylamino)ethylcarboxamide and other derivatives of 10H-quindoline
Junjie Chen, Leslie W Deady, Anthony J Kaye, et al.
Plos One
|
August 30, 2014
Relationships between signaling pathway usage and sensitivity to a pathway inhibitor: examination of trametinib responses in cultured breast cancer lines
Euphemia Y Leung, Ji Eun Kim, Marjan Askarian-Amiri, et al.
Cancer Chemotherapy and Pharmacology
|
September 17, 2013
Tumour tissue selectivity in the uptake and retention of SN 28049, a new topoisomerase II-directed anticancer agent
Pradeep B Lukka, Ying Yi Chen, Graeme J Finlay, et al.
Frontiers in Oncology
|
September 21, 2017
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
Euphemia Y Leung, Marjan E Askarian-Amiri, Debina Sarkar, et al.
Biology Direct
|
November 23, 2016
ZFAS1: a long noncoding RNA associated with ribosomes in breast cancer cells
Herah Hansji, Euphemia Y Leung, Bruce C Baguley, et al.
Cancer Chemotherapy and Pharmacology
|
May 8, 2014
Selective cellular uptake and retention of SN 28049, a new DNA-binding topoisomerase II-directed antitumor agent
Ying Yi Chen, Pradeep B Lukka, Wayne R Joseph, et al.
Page
of 3